Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2013 by Centre hospitalier de l'Université de Montréal (CHUM)
Sponsor:
Collaborators:
Université de Montréal
McGill University Health Center
Toronto General Hospital
Information provided by (Responsible Party):
Nancy Sheehan, Centre hospitalier de l'Université de Montréal (CHUM)
ClinicalTrials.gov Identifier:
NCT01627717
First received: June 21, 2012
Last updated: May 30, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2014
  Estimated Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)